HUM
Humana Inc
396.50$
-1.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 30.4% | 14.3% | 19.6% | 19.1% | 14.5% | 10.6% | 17.1% | 17.0% | 16.2% | 15.3% | 49.2% | 70.1% | |
| 27.1% | 10.0% | 11.8% | 11.0% | 10.2% | 4.8% | 8.3% | 8.0% | 10.8% | 8.6% | 9.0% | 12.1% | |
| 27.1% | 10.0% | 11.8% | 11.0% | 10.2% | 4.8% | 8.3% | 8.0% | 10.8% | 8.6% | 39.7% | 41.7% | |
| 3.3% | 4.3% | 7.8% | 8.2% | 4.3% | 5.8% | 8.8% | 8.9% | 5.4% | 6.7% | 9.4% | 10.0% | |
| -71.7% | -68.3% | -73.3% | -73.8% | – | – | – | – | – | – | – | – | |
| 6.0% | – | – | – | 5.4% | 5.5% | 4.8% | 4.7% | 4.6% | 4.6% | – | – | |
| 17.1% | 20.4% | 19.1% | 19.1% | 19.2% | 20.8% | 18.9% | 19.1% | 19.3% | 19.9% | 19.0% | 18.3% | |
| 3.2% | 3.6% | 3.4% | 3.3% | 3.3% | 3.1% | 2.8% | 2.7% | 2.5% | 2.3% | – | – | |
| 69.6% | 65.2% | 67.7% | 66.6% | 64.8% | 64.5% | 65.0% | 63.7% | 62.6% | 63.6% | 66.3% | 66.3% | |
| 35.7% | 25.5% | 25.7% | 25.8% | 24.9% | 24.3% | 24.1% | 22.5% | 20.8% | 21.2% | 38.9% | 40.2% | |
| 4.0% | 3.4% | 1.6% | 2.3% | 2.3% | 1.6% | 1.1% | 0.0% | 0.0% | 0.3% | 3.1% | 4.0% | |
| 18.2% | 21.5% | 23.4% | 22.8% | 22.2% | 22.2% | 22.5% | 22.0% | 20.3% | 20.1% | 34.8% | 22.5% | |
| 17.0% | 21.8% | 24.7% | 23.4% | 23.8% | 24.1% | 25.0% | 25.0% | 25.4% | 25.4% | 22.2% | 20.9% | |
| 30.3% | 34.7% | 32.2% | 33.3% | 35.1% | 35.4% | 34.9% | 36.2% | 37.3% | 36.2% | 33.6% | 33.6% | |
| 50.4% | 58.7% | 56.2% | 57.4% | 58.2% | 61.1% | 57.8% | 59.4% | 60.3% | 59.6% | 54.5% | 53.7% | |
| 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.